Bessemer Group
BNTX icon

Bessemer Group’s BioNTech BNTX Stock Holding History

Bessemer Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8K Buy
82
+43
+110% +$4.05K ﹤0.01% 2188
2026
Q1 		$3K Buy
39
+31
+388% +$3.19K ﹤0.01% 2307
2025
Q4 		$1K Buy
+8
New +$806 ﹤0.01% 2459
2024
Q2 		– Sell
-61
Closed -$6K – 2038
2024
Q1 		$6K Buy
+61
New +$5.85K ﹤0.01% 1661

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Bessemer Group's BNTX Position: Q2 2026 in Review

Bessemer Group increased its BioNTech (BNTX) stake by 110% in Q2 2026, buying an estimated $4.05K and bringing the position to 82 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #2188.

Bessemer Group first reported a position in BNTX in Q1 2024 and has held it in 4 quarters since. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Bessemer Group held 82 shares of BioNTech worth $8K as of Q2 2026.
  • Bessemer Group bought 43 BioNTech shares in Q2 2026, an estimated $4.05K.
  • BioNTech made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #2188 holding.
  • Bessemer Group first reported a position in BioNTech in Q1 2024 and has held it in 4 quarters since.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.